Company Filing History:
Years Active: 2020-2025
Title: Wanjun Tang: Innovator in Pharmaceutical Chemistry
Introduction
Wanjun Tang is a notable inventor based in Dongguan, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target acetyl-CoA carboxylase (ACC). With a total of 2 patents, his work has implications for the treatment and prevention of various diseases.
Latest Patents
Wanjun Tang's latest patents include "Thienopyrimidine derivatives having stereo configurations and use thereof in medicine" and "Thienopyrimidine derivative and use thereof in medicine." These inventions focus on pharmaceutical compositions that inhibit ACC, which plays a crucial role in metabolic regulation. The compounds and their formulations are designed for the treatment or prevention of diseases associated with ACC regulation in mammals, particularly humans.
Career Highlights
Wanjun Tang is currently associated with Sunshine Lake Pharma Co., Ltd., where he continues to advance his research in pharmaceutical innovations. His work is characterized by a strong emphasis on the practical applications of his inventions in medicine.
Collaborations
Wanjun has collaborated with notable colleagues, including Xinye Yang and Zheng Gu, to further enhance the impact of his research in the pharmaceutical industry.
Conclusion
Wanjun Tang's contributions to pharmaceutical chemistry, particularly through his innovative patents, highlight his role as a key figure in the development of new medical treatments. His work continues to pave the way for advancements in the field.